Breast Cancer

Three San Antonio studies target androgen in breast cancer

Three studies presented by University of Colorado Cancer Center researchers at the San Antonio Breast Cancer Symposium 2014 demonstrate the effects of blocking androgen receptors in breast cancer. One shows that, counterintuitively, ...

Dec 11, 2014
popularity not rated yet | comments 0

Merck advancing breast cancer drug to mid-stage

Drugmaker Merck & Co. said Wednesday that it will advance a new cancer drug into bigger patient tests, after promising findings in an early study against a very aggressive, common type of breast cancer.

Dec 10, 2014
popularity not rated yet | comments 0

Latest Spotlight News

Team finds key to tuberculosis resistance

The cascade of events leading to bacterial infection and the immune response is mostly understood. However, the molecular mechanisms underlying the immune response to the bacteria that causes tuberculosis ...